ResearcherUniversity of CologneNo recent work listed
Jiahui Li
Matched on ORCID iD 0009-0001-8800-7631; OpenAlex author ID A5114488774. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 32
2016: 2 papers · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 2 papers
Papers 8
- Expression of Immune Checkpoint Regulators IDO, VISTA, LAG3, and TIM3 in Resected Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers13112689↗
- IL-17B/RB Activation in Pancreatic Stellate Cells Promotes Pancreatic Cancer Metabolism and Growth. Co-author DOI 10.3390/cancers13215338↗
- The IL-17A/IL-17RA Axis Is Not Related to Overall Survival and Cancer Stem Cell Modulation in Pancreatic Cancer. Co-author DOI 10.3390/ijms21062215↗
- Inflammatory IFIT3 renders chemotherapy resistance by regulating post-translational modification of VDAC2 in pancreatic cancer. Co-author DOI 10.7150/thno.43093↗
- Tumor-Derived Extracellular Vesicles Inhibit Natural Killer Cell Function in Pancreatic Cancer. Co-author DOI 10.3390/cancers11060874↗
- Desmoplasia suppression by metformin-mediated AMPK activation inhibits pancreatic cancer progression. Co-author DOI 10.1016/j.canlet.2016.10.019↗
- Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer. First author DOI 10.1155/2016/1616781↗
- The Relevance of Nrf2 Pathway and Autophagy in Pancreatic Cancer Cells upon Stimulation of Reactive Oxygen Species. First author DOI 10.1155/2016/3897250↗
Closest collaborators
The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Felix Popp · 5 shared papers, 2019–2021 · strength 0.52
- Paper Expression of Immune Checkpoint Regulators IDO, VISTA, LAG3, and TIM3 in Resected Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers13112689↗
- Paper IL-17B/RB Activation in Pancreatic Stellate Cells Promotes Pancreatic Cancer Metabolism and Growth. DOI 10.3390/cancers13215338↗
- Paper The IL-17A/IL-17RA Axis Is Not Related to Overall Survival and Cancer Stem Cell Modulation in Pancreatic Cancer. DOI 10.3390/ijms21062215↗
- Christiane J. Bruns · 5 shared papers, 2019–2021 · strength 0.52
- Paper Expression of Immune Checkpoint Regulators IDO, VISTA, LAG3, and TIM3 in Resected Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers13112689↗
- Paper IL-17B/RB Activation in Pancreatic Stellate Cells Promotes Pancreatic Cancer Metabolism and Growth. DOI 10.3390/cancers13215338↗
- Paper The IL-17A/IL-17RA Axis Is Not Related to Overall Survival and Cancer Stem Cell Modulation in Pancreatic Cancer. DOI 10.3390/ijms21062215↗
- Yue Zhao · 5 shared papers, 2019–2021 · strength 0.52
- Paper Expression of Immune Checkpoint Regulators IDO, VISTA, LAG3, and TIM3 in Resected Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers13112689↗
- Paper IL-17B/RB Activation in Pancreatic Stellate Cells Promotes Pancreatic Cancer Metabolism and Growth. DOI 10.3390/cancers13215338↗
- Paper The IL-17A/IL-17RA Axis Is Not Related to Overall Survival and Cancer Stem Cell Modulation in Pancreatic Cancer. DOI 10.3390/ijms21062215↗
- Zhefang Wang · 3 shared papers, 2019–2021 · strength 0.29
- Paper IL-17B/RB Activation in Pancreatic Stellate Cells Promotes Pancreatic Cancer Metabolism and Growth. DOI 10.3390/cancers13215338↗
- Paper Inflammatory IFIT3 renders chemotherapy resistance by regulating post-translational modification of VDAC2 in pancreatic… DOI 10.7150/thno.43093↗
- Paper Tumor-Derived Extracellular Vesicles Inhibit Natural Killer Cell Function in Pancreatic Cancer. DOI 10.3390/cancers11060874↗
- Alexander Quaas · 2 shared papers, 2021 · strength 0.23
- Philipp Lohneis · 2 shared papers, 2020–2021 · strength 0.23
- Jiangang Zhao · 2 shared papers, 2019–2020 · strength 0.18
- Qingyong Ma · 3 shared papers, 2016–2017 · strength 0.16
- Paper Desmoplasia suppression by metformin-mediated AMPK activation inhibits pancreatic cancer progression. DOI 10.1016/j.canlet.2016.10.019↗
- Paper Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer. DOI 10.1155/2016/1616781↗
- Paper The Relevance of Nrf2 Pathway and Autophagy in Pancreatic Cancer Cells upon Stimulation of Reactive Oxygen Species. DOI 10.1155/2016/3897250↗
- Zhengdong Jiang · 3 shared papers, 2016–2017 · strength 0.16
- Paper Desmoplasia suppression by metformin-mediated AMPK activation inhibits pancreatic cancer progression. DOI 10.1016/j.canlet.2016.10.019↗
- Paper Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer. DOI 10.1155/2016/1616781↗
- Paper The Relevance of Nrf2 Pathway and Autophagy in Pancreatic Cancer Cells upon Stimulation of Reactive Oxygen Species. DOI 10.1155/2016/3897250↗
- Xuqi Li · 3 shared papers, 2016–2017 · strength 0.16
- Paper Desmoplasia suppression by metformin-mediated AMPK activation inhibits pancreatic cancer progression. DOI 10.1016/j.canlet.2016.10.019↗
- Paper Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer. DOI 10.1155/2016/1616781↗
- Paper The Relevance of Nrf2 Pathway and Autophagy in Pancreatic Cancer Cells upon Stimulation of Reactive Oxygen Species. DOI 10.1155/2016/3897250↗
- Alexander Ioannis Damanakis · 1 shared paper, 2021 · strength 0.12
- Heike Löser · 1 shared paper, 2021 · strength 0.12
- Rainer Lothar Heuchel · 1 shared paper, 2021 · strength 0.11
- Zhenhua Ma · 2 shared papers, 2016–2017 · strength 0.11
- Jianjun Lei · 2 shared papers, 2016–2017 · strength 0.10
- Wanxing Duan · 2 shared papers, 2016–2017 · strength 0.10
- Qinhong Xu · 2 shared papers, 2016–2017 · strength 0.10
- Wei Li · 2 shared papers, 2016 · strength 0.10
- Tao Shan · 2 shared papers, 2016 · strength 0.10
- Liang Zong · 2 shared papers, 2016 · strength 0.10
- Lun Zhang · 2 shared papers, 2016 · strength 0.10
- Qiongzhu Dong · 1 shared paper, 2020 · strength 0.10
- Bo Kong · 1 shared paper, 2020 · strength 0.10
- Hans Schlößer · 1 shared paper, 2019 · strength 0.08
- Zheng Wu · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.